Clinical trial Recruiting at 1 site Interventional Ages 18 to 99

Identifying new markers to predict gestational diabetes and large babies.

Official title: New Markers of Glycation to Predict Gestational Diabetes Mellitus and Macrosomia.

Run by University Hospital, Bordeaux · NCT06048510 · Data updated 2026-11-12

This study is testing new ways to predict gestational diabetes and large babies in pregnant women by looking at specific markers in their blood to see if they work better than the usual tests.

Quick facts

Study typeInterventional
Ages18 Years to 99 Years
SexAll
Enrollment800 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations1 site (Bordeaux)
StatusRecruiting
StartedDecember 18, 2023
Main results expectedSeptember 2028
Study endsSeptember 2028
Registry record updatedJanuary 15, 2026
Trial IDNCT06048510 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant women aged 18 years and older, with a singleton pregnancy and less than 28 weeks of gestation.

Probably not a fit

Patients who have known diabetes prior to pregnancy or are beyond 28 weeks of gestation will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate new glycation markers, specifically skin autofluorescence and glycated albumin, as predictors of gestational diabetes mellitus (GDM) and macrosomia in pregnant women. It compares these novel markers to the traditional HbA1c measurement to determine their effectiveness in identifying risks for adverse pregnancy outcomes. The study will involve pregnant women who are less than 28 weeks into their pregnancy and will assess their glycation levels to improve screening strategies for GDM. The goal is to enhance early detection and management of these conditions.

Why it matters

Potential benefit: If successful, this study could lead to improved screening methods for gestational diabetes and better outcomes for mothers and infants.

How similar studies have gone: While the use of glycation markers in this context is innovative, similar studies have shown promise in identifying risks associated with gestational diabetes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

1. Age ≥ 18 years
2. Singleton pregnancy (or twin pregnancy reduced spontaneously or medically before 14 weeks of amenorrhea)
3. Gestational age at inclusion \<28 weeks of amenorrhea
4. Participant affiliated with or beneficiary of a social security scheme
5. Collection of patient consent.

Exclusion criteria:

1. Gestational age at inclusion ≥ 28 weeks of amenorrhea
2. Multiple pregnancy
3. Known diabetes prior to pregnancy
4. History of bariatric surgery
5. Expected delivery in another maternity unit not participating in the study
6. Person deprived of liberty by judicial or administrative decision
7. Guardianship or curatorship
8. Participant not affiliated or not benefiting from a social security scheme.

Where it's running

  • Hopital Pellegrin
    Bordeaux, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.